Frontiers in Molecular Neuroscience,
Год журнала:
2024,
Номер
17
Опубликована: Ноя. 22, 2024
Neurogenesis
has
emerged
as
a
promising
therapeutic
approach
for
central
nervous
system
disorders.
The
role
of
neuronal
mitochondria
in
neurogenesis
is
well-studied,
however,
recent
evidence
underscores
the
critical
astrocytic
mitochondrial
function
regulating
and
underlying
mechanisms
remain
incompletely
understood.
This
review
highlights
regulatory
effects
astrocyte
on
neurogenesis,
focusing
metabolic
support,
calcium
homeostasis,
secretion
neurotrophic
factors.
effect
dysfunction
pathophysiology
treatment
strategies
Alzheimer’s
disease
depression
discussed.
Greater
attention
needed
to
investigate
autophagy,
dynamics,
biogenesis,
energy
metabolism
neurogenesis.
Targeting
presents
potential
strategy
enhancing
neural
regeneration.
Life,
Год журнала:
2024,
Номер
14(2), С. 196 - 196
Опубликована: Янв. 30, 2024
Alzheimer’s
disease
(AD)
is
a
progressive
and
incurable
neurodegenerative
disorder
that
primarily
affects
persons
aged
65
years
above.
It
causes
dementia
with
memory
loss
deterioration
in
thinking
language
skills.
AD
characterized
by
specific
pathology
resulting
from
the
accumulation
brain
of
extracellular
plaques
amyloid-β
intracellular
tangles
phosphorylated
tau.
The
importance
mitochondrial
dysfunction
pathogenesis,
while
previously
underrecognized,
now
more
appreciated.
Mitochondria
are
an
essential
organelle
involved
cellular
bioenergetics
signaling
pathways.
Mitochondrial
processes
crucial
for
synaptic
activity
such
as
mitophagy,
trafficking,
fission,
fusion
dysregulated
brain.
Excess
fission
fragmentation
yield
mitochondria
low
energy
production.
Reduced
glucose
metabolism
also
observed
hypometabolic
state,
particularly
temporo-parietal
regions.
This
review
addresses
multiple
ways
which
abnormal
structure
function
contribute
to
AD.
Disruption
electron
transport
chain
ATP
production
neurotoxic
because
cells
have
disproportionately
high
demands.
In
addition,
oxidative
stress,
extremely
damaging
nerve
cells,
rises
dramatically
dyshomeostasis.
Restoring
health
may
be
viable
approach
treatment.
Molecular Neurodegeneration,
Год журнала:
2025,
Номер
20(1)
Опубликована: Янв. 13, 2025
Astrocytes,
the
most
abundant
glial
cell
type
in
brain,
will
convert
into
reactive
state
response
to
proteotoxic
stress
such
as
tau
accumulation,
a
characteristic
feature
of
Alzheimer's
disease
(AD)
and
other
tauopathies.
The
formation
astrocytes
is
partially
attributed
disruption
autophagy
lysosomal
signaling,
inhibiting
some
histone
deacetylases
(HDACs)
has
been
demonstrated
reduce
molecular
functional
characteristics
astrocytes.
However,
precise
role
signaling
that
regulates
pathology
remains
unclear.
We
investigated
expression
class
IIa
HDAC7
from
AD
patients
PS19
mice.
mice
were
treated
with
AAVs
expressing
shRNA
for
astrocyte-specific
promoter
selective
HDAC
inhibitor,
TMP195,
effects
on
pathology,
gliosis,
synaptic
plasticity
cognition-related
behavioral
performance
measured.
Tau
uptake
degradation
assays
cultured
utilized
investigate
astrocyte-mediated
clearance.
Immunoprecipitation,
immunofluorescence,
western
blotting,
RT-qPCR,
mass
spectrometric,
luciferase
reporter
assay
used
identify
substrates,
modification
site
related
pathways
astrocyte-tau
generated
new
antibody
clarify
HDAC7-mediated
Here,
we
found
level
deacetylase
7
(HDAC7)
was
remarkably
increased
P301S
transgenic
(PS19)
Genetic
or
pharmacological
inhibition
effectively
enhanced
astrocytic
clearance
improved
cognitive
functions
could
modulate
proteins
through
transcriptional
factor
EB
(TFEB)
acetylation-dependent
manner.
Specifically,
deacetylation
TFEB
at
K310
by
prevented
nuclear
translocation
reduced
biogenesis
astrocytes,
whereas
restored
acetylation
Our
findings
suggest
upregulation
induces
AD-like
pathologies
via
deacetylating
downregulating
HDAC7-TFEB
promising
arresting
Journal of Neurochemistry,
Год журнала:
2025,
Номер
169(3)
Опубликована: Март 1, 2025
ABSTRACT
Synaptic
homeostasis
of
the
principal
neurotransmitters
glutamate
and
GABA
is
tightly
regulated
by
an
intricate
metabolic
coupling
between
neurons
astrocytes
known
as
glutamate/GABA‐glutamine
cycle.
In
this
cycle,
take
up
from
synapse
convert
these
into
glutamine.
Astrocytic
glutamine
subsequently
transferred
to
neurons,
serving
precursor
for
neuronal
synthesis.
The
cycle
integrates
multiple
cellular
processes,
including
neurotransmitter
release,
uptake,
synthesis,
metabolism.
All
processes
are
deeply
interdependent
closely
coupled
energy
Astrocytes
display
highly
active
mitochondrial
oxidative
metabolism
several
unique
features,
glycogen
storage
pyruvate
carboxylation,
which
essential
sustain
continuous
release.
However,
new
roles
oligodendrocytes
microglia
in
recycling
emerging.
Malfunction
can
lead
severe
synaptic
disruptions
may
be
implicated
brain
diseases.
Here,
I
review
central
aspects
recent
advances
highlight
how
functionally
connected
critical
functions
First,
overview
glutamate,
GABA,
transport
provided
relation
recycling.
Then,
reviewed,
with
a
special
emphasis
on
glial
cells.
Finally,
discuss
aberrant
linked
neurodegeneration
disease,
focusing
astrocyte
dysfunction
lipid
emerging
pathological
mechanisms.
Instead
viewing
individual
biochemical
more
holistic
integrative
approach
needed
advance
our
understanding
modulates
function
both
health
disease.
image
Lipid
droplets
(LDs)
are
dynamic
cytoplasmic
lipid-storing
organelles
that
play
a
pivotal
role
in
maintaining
cellular
energy
balance,
lipid
homeostasis,
and
metabolic
signaling.
Dysregulation
of
metabolism,
particularly
excessive
lipogenesis,
contributes
to
the
abnormal
accumulation
LDs
nervous
system,
which
is
associated
with
several
neurodegenerative
diseases.
Circular
RNAs
(circRNAs)
new
class
non-coding
regulatory
widely
expressed
eukaryotes.
However,
only
subset
has
been
functionally
characterized.
Here,
we
identified
characterized
circular
RNA
circbabo(5,6,7,8S)
regulates
lipogenesis
neuronal
integrity
Drosophila
melanogaster.
derived
from
babo
locus
encodes
type
I
receptor
for
transforming
growth
factor
β
(TGF-β).
Depletion
flies
causes
elevated
droplet
accumulation,
progressive
photoreceptor
cell
loss
shortened
lifespan,
phenotypes
rescued
by
restoring
expression.
In
addition,
RNA-seq
epistasis
analyses
reveal
these
abnormalities
caused
aberrant
activation
SREBP
signaling
pathway.
Furthermore,
circbabo(5,6,7,8S)-depleted
tissues
display
enhanced
TGF-β
pathway
compromised
mitochondrial
function,
resulting
upregulation
reactive
oxygen
species
(ROS).
Moreover,
provide
evidence
protein
circbabo(5,6,7,8S)-p,
inhibits
interfering
assembly
babo/put
heterodimer
complex.
Lastly,
show
dysregulation
ROS/JNK/SREBP
cascade
responsible
LD
neurodegeneration,
lifespan
elicited
depletion.
Our
study
demonstrates
physiological
protein-coding
circRNA
regulating
metabolism
integrity.
Journal of Neuroinflammation,
Год журнала:
2025,
Номер
22(1)
Опубликована: Март 10, 2025
Abstract
Astrocytes
are
a
major
cell
type
in
the
central
nervous
system
(CNS)
that
play
key
role
regulating
homeostatic
functions,
responding
to
injuries,
and
maintaining
blood-brain
barrier.
also
regulate
neuronal
functions
survival
by
modulating
myelination
degradation
of
pathological
toxic
protein
aggregates.
have
recently
been
proposed
possess
both
autophagic
activity
active
phagocytic
capability
which
largely
depend
on
sufficiently
acidified
lysosomes
for
complete
cellular
cargos.
Defective
lysosomal
acidification
astrocytes
impairs
their
resulting
accumulation
debris,
excessive
myelin
lipids,
aggregates,
ultimately
contributes
propagation
neuroinflammation
neurodegenerative
pathology.
Restoration
impaired
represent
new
neuroprotective
strategy
therapeutic
direction.
In
this
review,
we
summarize
pathogenic
factors,
including
neuroinflammatory
signaling,
metabolic
stressors,
lipid
mediated
toxicity,
contribute
impairment
associated
dysfunction
astrocytes.
We
discuss
astrocyte-mediated
primarily
context
diseases
along
with
other
brain
injuries.
then
highlight
re-acidification
as
restore
well
degradative
capacity
conclude
providing
future
perspectives
phagocytes
crosstalk
CNS
cells
impart
or
effects.
CNS Neuroscience & Therapeutics,
Год журнала:
2024,
Номер
30(3)
Опубликована: Март 1, 2024
Abstract
Background
Accumulation
of
amyloid
beta,
tau
hyperphosphorylation,
and
microglia
activation
are
the
three
highly
acknowledged
pathological
factors
Alzheimer's
disease
(AD).
However,
oligodendrocytes
(OLs)
were
also
widely
investigated
in
pathogenesis
treatment
for
AD.
Aims
We
aimed
to
update
regulatory
targets
differentiation
maturation
OLs,
emphasized
key
role
OLs
occurrence
Methods
This
review
first
concluded
OL
with
AD
pathogenesis,
then
advanced
based
on
both
clinic
basic
experiments.
Later,
we
extensively
discussed
possible
application
current
progress
diagnosis
this
complex
disease.
Results
Molecules
involving
OLs’
or
maturation,
including
various
transcriptional
factors,
cholesterol
homeostasis
regulators,
microRNAs
could
participate
Clinical
data
point
towards
impairment
patients.
Basic
research
further
supports
central
regulation
pathologies.
Additionally,
classic
drugs,
donepezil,
edaravone,
fluoxetine,
clemastine
demonstrate
their
potential
remedying
models,
new
therapeutics
from
perspective
is
constantly
being
developed.
Conclusions
believe
that
dysfunction
one
important
Factors
regulating
might
be
biomarkers
early
agents
stimulating
warrant
development
anti‐AD
drugs.
Translational Neurodegeneration,
Год журнала:
2024,
Номер
13(1)
Опубликована: Окт. 29, 2024
Abstract
Background
Persistent
innate
and
adaptive
immune
responses
in
the
brain
contribute
to
progression
of
Alzheimer’s
disease
(AD).
APOE4
,
most
important
genetic
risk
factor
for
sporadic
AD,
encodes
apolipoprotein
E4,
which
by
itself
is
a
potent
modulator
response.
However,
little
known
about
hub
that
governs
crosstalk
between
nervous
systems.
Transient
receptor
potential
vanilloid
type
1
(TRPV1)
channel
ligand-gated,
nonselective
cation
with
Ca
2+
permeability,
has
been
proposed
as
neuroprotective
target
AD.
Methods
Using
-sensitive
dyes,
dynamic
changes
microglia
were
measured,
including
exogenous
uptake
endoplasmic
reticulum
release.
The
mRFP-GFP-tagged
LC3
plasmid
was
expressed
characterize
role
TRPV1
autophagic
flux.
Transcriptomic
analyses
flow
cytometry
performed
investigate
effects
on
T
cells
from
APOE
-targeted
replacement
mice
microglia-specific
gene
deficiency.
Results
Both
derived
induced
pluripotent
stem
AD
patients
-related
tauopathy
mouse
model
showed
significantly
increased
cholesterol
biosynthesis
accumulation
compared
their
APOE3
counterparts.
Further,
dysregulation
associated
persistent
activation
elevation
major
histocompatibility
complex
II-dependent
antigen
presentation
microglia,
subsequently
accompanied
cell
infiltration.
In
addition,
TRPV1-mediated
transient
influx
mitigated
suppressing
transcriptional
sterol
regulatory
element-binding
protein
2,
promoted
activity
reduced
lysosomal
accumulation,
sufficient
resolve
excessive
response
neurodegeneration
model.
Moreover,
deficiency
accelerated
glial
inflammation,
an
Conclusions
findings
provide
new
perspectives
treatment
-dependent